Hyeon-Cheol Jeong

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 6

Top Topics

Coronavirus Disease

Ultra High Performance Liquid Chromatography

Mass Spectrometry

Top Venues

Translational and clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Hyeon-Cheol Jeong, Yoon-Jee Chae, Kwang-Hee Shin
Predicting the systemic exposure and lung concentration of nafamostat using physiologically-based pharmacokinetic modeling. Translational and clinical pharmacology 30 (4) (2022)
Zhuodu Wei, Hyeon-Cheol Jeong, Ye-Ji Kang, Jaesang Jang, Myoung-Hwan Kim, Kwang-Hee Shin
Bioanalytical methods for the detection of duloxetine and thioctic acid in plasma using ultra performance liquid chromatography with tandem mass spectrometry (UPLC-MS/MS). Translational and clinical pharmacology 30 (2) (2022)
Hyeon-Cheol Jeong, Yoon-Jee Chae, Kwang-Hee Shin
Predicting the systemic exposure and lung concentration of nafamostat using physiologically-based pharmacokinetic modeling. Translational and clinical pharmacology 30 (4) (2022)
Hyeon-Cheol Jeong, Min-Gul Kim, Zhuodu Wei, Kyeong-Ryoon Lee, Jaehyeok Lee, Im Sook Song, Kwang-Hee Shin
Integration of a Physiologically Based Pharmacokinetic and Pharmacodynamic Model for Tegoprazan and Its Metabolite: Application for Predicting Food Effect and Intragastric pH Alterations. Pharmaceutics 14 (6) (2022)
Hyeon-Cheol Jeong, Yo-Han Seo, Namyi Gu, Moo-Yong Rhee, Kwang-Hee Shin
Determination of candesartan or olmesartan in hypertensive patient plasma using UPLC-MS/MS. Translational and clinical pharmacology 29 (4) (2021)
Joomi Lee, Min Gul Kim, Hyeon-Cheol Jeong, Kwang-Hee Shin
Physiologically-based pharmacokinetic model for clozapine in Korean patients with schizophrenia. Translational and clinical pharmacology 29 (1) (2021)